Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,302,537
-
Share change
-
+6,413,535
-
Total reported value
-
$98,415,638
-
Put/Call ratio
-
14%
-
Price per share
-
$2.87
-
Number of holders
-
87
-
Value change
-
-$19,872,150
-
Number of buys
-
50
-
Number of sells
-
52
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q4 2018
As of 31 Dec 2018,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,302,537 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, JENNISON ASSOCIATES LLC, Granite Point Capital Management, L.P., BlackRock Inc., FRANKLIN RESOURCES INC, Vanguard Group Inc, GOLDMAN SACHS GROUP INC, Jefferies Group LLC, 683 Capital Management, LLC, and VHCP Management III, LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.